Carisma Therapeutics Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
3675 MARKET STREET, PHILADELPHIA, PA, 19104
Mailing Address
3675 MARKET STREET, PHILADELPHIA, PA, 19104
Phone
2674916422
Fiscal Year End
1231
EIN
262025616
Financial Overview
FY2024
$89.55M
Total Assets
$-1.46
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | December 5, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | October 15, 2025 | View on SEC |
| 8-K Current report of material events | October 9, 2025 | View on SEC |
| 4 Insider stock transaction report | October 8, 2025 | View on SEC |
| 4 Insider stock transaction report | October 3, 2025 | View on SEC |
| 8-K Current report of material events | September 18, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | September 2, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | August 29, 2025 | View on SEC |
| 8-K Current report of material events | August 29, 2025 | View on SEC |
Material Events
8-K
Financial Distress
December 5, 2025
High Impact
- Carisma Therapeutics Inc. is voluntarily delisting its stock from the Nasdaq exchange.
- The company plans to stop filing regular financial reports with the SEC.
Related Companies
Companies in the same industry (SIC: 2834)
NERVGEN PHARMA CORP.
NGEN
Pharmaceutical Preparations
Connect Biopharma Holdings Ltd
CNTB
Pharmaceutical Preparations
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT
Pharmaceutical Preparations
TuHURA Biosciences, Inc./NV
HURA
Pharmaceutical Preparations
Canton Strategic Holdings, Inc.
CNTN
Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.